WASF3 and breast cancer: The most significant finding of this analysis is the fact that WAVE3 expression levels were significantly higher in the blood of patients with the TNBC subtype disease compared to the other BC subtypes (p<2.2×10−16), clearly demonstrating that WAVE3 expression levels can distinguish this very aggressive subtype of BC from the other subtypes.